Literature DB >> 29439016

PSMA-Targeted Radionuclide Therapy and Salivary Gland Toxicity: Why Does It Matter?

David Taïeb1, Jean-Marc Foletti2, Manuel Bardiès3,4, Palma Rocchi5, Rodney J Hicks6, Uwe Haberkorn7,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29439016     DOI： 10.2967/jnumed.118.207993

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  23 in total

1.  Comparison of Prostate-Specific Membrane Antigen Expression Levels in Human Salivary Glands to Non-Human Primates and Rodents.

Authors:  Jyoti Roy; Blake M Warner; Falguni Basuli; Xiang Zhang; Karen Wong; Thomas Pranzatelli; Anita T Ton; John A Chiorini; Peter L Choyke; Frank I Lin; Elaine M Jagoda
Journal:  Cancer Biother Radiopharm       Date:  2020-02-19       Impact factor: 3.099

2.  Evaluation of 111In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen.

Authors:  Sangeeta Ray Banerjee; Vivek Kumar; Ala Lisok; Donika Plyku; Zora Nováková; Mary Brummet; Bryan Wharram; Cyril Barinka; Robert Hobbs; Martin G Pomper
Journal:  J Nucl Med       Date:  2018-09-20       Impact factor: 10.057

Review 3.  Looking for Drugs in All the Wrong Places: Use of GCPII Inhibitors Outside the Brain.

Authors:  James J Vornov; Diane Peters; Mike Nedelcovych; Kristen Hollinger; Rana Rais; Barbara S Slusher
Journal:  Neurochem Res       Date:  2019-11-20       Impact factor: 3.996

Review 4.  Renal Cell Carcinoma: the Oncologist Asks, Can PSMA PET/CT Answer?

Authors:  Chiara Pozzessere; Maria Bassanelli; Anna Ceribelli; Sazan Rasul; Shuren Li; John O Prior; Francesco Cicone
Journal:  Curr Urol Rep       Date:  2019-10-11       Impact factor: 3.092

5.  Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLT.

Authors:  Hendrik Rathke; Clemens Kratochwil; Ralph Hohenberger; Frederik Lars Giesel; Frank Bruchertseifer; Paul Flechsig; Alfred Morgenstern; Matti Hein; Peter Plinkert; Uwe Haberkorn; Olcay Cem Bulut
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-27       Impact factor: 9.236

6.  177Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy.

Authors:  Sangeeta Ray Banerjee; Vivek Kumar; Ala Lisok; Jian Chen; Il Minn; Mary Brummet; Srikanth Boinapally; Michael Cole; Ethel Ngen; Bryan Wharram; Cory Brayton; Robert F Hobbs; Martin G Pomper
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-10       Impact factor: 9.236

7.  68Ga-PSMA PET/CT: effect of external cooling on salivary gland uptake.

Authors:  Matheus Zanelatto Junqueira; Nelisa Helena Rocha; Marcelo Tatit Sapienza
Journal:  Radiol Bras       Date:  2021 May-Jun

8.  A PSMA-targeted bispecific antibody for prostate cancer driven by a small-molecule targeting ligand.

Authors:  Sung Chang Lee; Jennifer S Y Ma; Min Soo Kim; Eduardo Laborda; Sei-Hyun Choi; Eric N Hampton; Hwayoung Yun; Vanessa Nunez; Michelle T Muldong; Christina N Wu; Wenxue Ma; Anna A Kulidjian; Christopher J Kane; Vadim Klyushnichenko; Ashley K Woods; Sean B Joseph; Mike Petrassi; John Wisler; Jing Li; Christina A M Jamieson; Peter G Schultz; Chan Hyuk Kim; Travis S Young
Journal:  Sci Adv       Date:  2021-08-11       Impact factor: 14.136

Review 9.  Molecular Imaging, How Close to Clinical Precision Medicine in Lung, Brain, Prostate and Breast Cancers.

Authors:  Zhaoguo Han; Mingxing Ke; Xiang Liu; Jing Wang; Zhengqi Guan; Lina Qiao; Zhexi Wu; Yingying Sun; Xilin Sun
Journal:  Mol Imaging Biol       Date:  2021-07-16       Impact factor: 3.488

10.  Competitive blocking of salivary gland [18F]DCFPyL uptake via localized, retrograde ductal injection of non-radioactive DCFPyL: a preclinical study.

Authors:  Jyoti Roy; Blake M Warner; Falguni Basuli; Xiang Zhang; Changyu Zheng; Corrine Goldsmith; Tim Phelps; Karen Wong; Anita T Ton; Rick Pieschl; Margaret E White; Rolf Swenson; John A Chiorini; Peter L Choyke; Frank I Lin
Journal:  EJNMMI Res       Date:  2021-07-21       Impact factor: 3.138
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.